These findings suggest that COX2 may mainly contribute to early steps in melanoma progression, that is, growth and invasion of primary MM, and becomes less essential in the advanced metastatic setting of melanoma disease. This evidence concerns the gene PTGS2 and Miyoshi myopathy.